The SCPC applies state-of-the-art quantitative mass spectrometry-based proteomics and metabolomics methods for research, provides services to the academic, pharmaceutical and biotechnology groups, and translates quantitative mass spectrometry assays to the clinic. The Jewish General Hospital Proteomics Centre encompasses the Segal Cancer Proteomics Centre (SCPC) and the Warren Y. Soper Program in Translational Proteomics.
Research
- (Fundamental) method听 听 听development
- MultiOMICS for personalized听听medicine
- 笔谤辞迟别辞驳别辞苍辞尘颈肠蝉听
听
Translation
- 听Targeted MS assays for the clinic
Services
- Identification of PTMs
- Relative quantitative proteomics and phosphoproteomics
- Targeted quantitative MS听proteomics & metabolomics
- MultiOMICS
- Protein-protein interactions
听
听
听
听
听
听
听
听
听
听
听
听
For more information please visit out other website:听
听
Our technologies can be applied to a wide range of samples, from purified proteins and protein complexes to biofluids, cells, biopsies and FFPE tissues, requiring only minimal sample amounts (e.g. few 碌L of blood; few 碌g of total protein from cells and tissues).听
听
听
The Segal Cancer Proteomics Centre is part of two Pan-Canadian networks, TMIC ()听and PCPC ()
听
听